S0502: A SWOG phase III randomized study of imatinib, with or without bevacizumab, in patients with untreated metastatic or unresectable gastrointestinal stromal tumors

Charles D. Blanke, Cathy Rankin, Christopher Corless, Janet F. Eary, Karen Mulder, Scott H. Okuno, Suzanne George, Michael Heinrich

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'S0502: A SWOG phase III randomized study of imatinib, with or without bevacizumab, in patients with untreated metastatic or unresectable gastrointestinal stromal tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences